PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
17-Oct-2023 HighRun DataScience Launches Data Science Platform for Global Customers HighRun DataScience
17-Oct-2023 CD BioSciences Launches New Services to Study Catabolism in Diabetes CD BioSciences
17-Oct-2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA ImmunOs Therapeutics
16-Oct-2023 Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder Teva Pharmaceuticals
13-Oct-2023 AbbVie Announces Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo as Program Advances to Phase 3 AbbVie
13-Oct-2023 Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster Phesi
13-Oct-2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa UCB
12-Oct-2023 Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards CluePoints
12-Oct-2023 AlzeCure presents clinical phase II-data with ACD440 for neuropathic pain at pain conference AlzeCure
12-Oct-2023 CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research CD Bioparticles
11-Oct-2023 PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting PureTech
11-Oct-2023 Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study with CyPep-1 in Solid Tumors Cytovation ASA
11-Oct-2023 Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions Roche
11-Oct-2023 Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies Roche
10-Oct-2023 Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology Valo Therapeutics
10-Oct-2023 GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1 GPCR Therapeutics
10-Oct-2023 Mission Therapeutics to Present at Michael J. Fox Foundation’s 15th Annual Parkinson’s Disease Therapeutics Conference Mission Therapeutics
10-Oct-2023 New guidance launches to enhance quality and improve patient experience in healthcare sector BSI
10-Oct-2023 Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention Innovative Trials
10-Oct-2023 Life sciences leaders unite to condemn radical plans to rewrite medicines scheme British Pharmaceutical Industry (ABPI)